TY - JOUR
T1 - Prevalence and classification of hallucinations in multiple sensory modalities in schizophrenia spectrum disorders
AU - Lim, Anastasia
AU - Hoek, Hans W.
AU - Deen, Mathijs L.
AU - Blom, Jan Dirk
AU - Bruggeman, Richard
AU - Cahn, Wiepke
AU - de Haan, Lieuwe
AU - Kahn, René S.
AU - Meijer, Carin J.
AU - Myin-Germeys, Inez
AU - van Os, Jim
AU - Wiersma, Durk
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Background Auditory hallucinations are experienced by 60–80% of all patients diagnosed with a schizophrenia spectrum disorder. However, in this patient group, the prevalence of hallucinations in multiple sensory modalities, i.e. multimodal hallucinations (MMHs), is unknown. Aims To assess the prevalence of MMHs in patients diagnosed with a schizophrenia spectrum disorder, data were analyzed from 750 patients who participated in the Dutch Genetic Risk and Outcome of Psychosis (GROUP) study. Method We drew on the section of the CASH (Comprehensive Assessment of Symptoms and History) that probes into the lifetime presence of auditory, visual, somatic/tactile, and olfactory hallucinations. Results A lifetime prevalence of 80% was found in this group for hallucinations in any of these modalities. Within the whole group, 27% of the participants reported unimodal hallucinations and 53% MMHs. There were no significant differences in prevalence rate for Dutch versus migrant participants from Morocco, Turkey, Surinam or the (former) Dutch Antilles. Conclusion We conclude that MMHs, rather than auditory hallucinations, are the most frequent perceptual symptom of patients diagnosed with a schizophrenia spectrum disorder. Our data also suggest that hallucinations experienced in a single sensory modality (notably auditory ones) stochastically increase the risk for more sensory modalities to join in. We recommend that future studies take into account all 14 sensory modalities in which hallucinations can be experienced. For this we provide a classification of MMHs that allows characterization of their serial versus simultaneous occurrence and their congruent versus incongruent nature.
AB - Background Auditory hallucinations are experienced by 60–80% of all patients diagnosed with a schizophrenia spectrum disorder. However, in this patient group, the prevalence of hallucinations in multiple sensory modalities, i.e. multimodal hallucinations (MMHs), is unknown. Aims To assess the prevalence of MMHs in patients diagnosed with a schizophrenia spectrum disorder, data were analyzed from 750 patients who participated in the Dutch Genetic Risk and Outcome of Psychosis (GROUP) study. Method We drew on the section of the CASH (Comprehensive Assessment of Symptoms and History) that probes into the lifetime presence of auditory, visual, somatic/tactile, and olfactory hallucinations. Results A lifetime prevalence of 80% was found in this group for hallucinations in any of these modalities. Within the whole group, 27% of the participants reported unimodal hallucinations and 53% MMHs. There were no significant differences in prevalence rate for Dutch versus migrant participants from Morocco, Turkey, Surinam or the (former) Dutch Antilles. Conclusion We conclude that MMHs, rather than auditory hallucinations, are the most frequent perceptual symptom of patients diagnosed with a schizophrenia spectrum disorder. Our data also suggest that hallucinations experienced in a single sensory modality (notably auditory ones) stochastically increase the risk for more sensory modalities to join in. We recommend that future studies take into account all 14 sensory modalities in which hallucinations can be experienced. For this we provide a classification of MMHs that allows characterization of their serial versus simultaneous occurrence and their congruent versus incongruent nature.
KW - Compound hallucination
KW - Multimodal hallucination
KW - Panoramic hallucination
KW - Polymodal hallucination
KW - Stochastic process
KW - Unimodal hallucination
UR - http://www.scopus.com/inward/record.url?scp=84977572584&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2016.06.010
DO - 10.1016/j.schres.2016.06.010
M3 - Article
C2 - 27349814
AN - SCOPUS:84977572584
SN - 0920-9964
VL - 176
SP - 493
EP - 499
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 2-3
ER -